Physician profile
Karima A Gulwani
NPI 1003475286
$491.11
in general payments reported to CMS, 2019-2025
9 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $69.22 · 2023: $133 · 2024: $112 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $132.24 | 2025 | Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $116.24 | 2023-2024 | |
| Lilly USA, LLC | $56.51 | 2023 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $50.71 | 2022-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $35.92 | 2022-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Phathom Pharmaceuticals, INC. | $27.55 | 2024 | Voquezna |
| Phadia US INC. | $24.62 | 2023 | Immunocap |
| Novo Nordisk INC | $24.50 | 2022 | |
| Hologic Sales and Service, LLC | $22.82 | 2025 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karima Gulwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.